Correction to “Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis”

IF 6.1 2区医学 Q1 ONCOLOGY

Cancer Pub Date : 2025-07-18 DOI:10.1002/cncr.70003

引用次数: 0

Abstract

Beaussant Y, Tarbi E, Nigam K, et al. Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: qualitative analysis. Cancer. 2024;130(7):1147-1157. doi:10.1002/cncr.35024

In addition to the affiliations cited in the published article, Michael Ljuslin is affiliated with the Department of Psychosocial Oncology and Palliative Care at the Dana–Farber Cancer Institute in Boston, Massachusetts.

Moreover, Ljuslin's ORCID identifier, https://orcid.org/0000-0002-2386-1749, was inadvertently not included.

We apologize for these errors.

查看原文本刊更多论文

对“癌症和重度抑郁症患者裸盖菇素辅助团体治疗的可接受性：定性分析”的修正

刘建军，李建军，李建军，等。裸盖菇素辅助团体治疗癌症合并重度抑郁症患者的可接受性：定性分析。癌症。2024;130(7):1147 - 1157。doi: 10.1002 / cncr。35024除了发表文章中提到的附属机构外，Michael Ljuslin还隶属于马萨诸塞州波士顿的Dana-Farber癌症研究所的社会心理肿瘤学和姑息治疗部门。此外，Ljuslin的ORCID标识符https://orcid.org/0000-0002-2386-1749无意中没有包括在内。我们为这些错误道歉。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cancer 医学-肿瘤学

CiteScore

13.10

自引率

3.20%

发文量

480

审稿时长

2-3 weeks

期刊介绍： The CANCER site is a full-text, electronic implementation of CANCER, an Interdisciplinary International Journal of the American Cancer Society, and CANCER CYTOPATHOLOGY, a Journal of the American Cancer Society. CANCER publishes interdisciplinary oncologic information according to, but not limited to, the following disease sites and disciplines: blood/bone marrow; breast disease; endocrine disorders; epidemiology; gastrointestinal tract; genitourinary disease; gynecologic oncology; head and neck disease; hepatobiliary tract; integrated medicine; lung disease; medical oncology; neuro-oncology; pathology radiation oncology; translational research